病理特征 | n | FAK | PI3K | p-AKt | p-mTOR | ||||||||
阳性 | 阴性 | 阳性率 | 阳性 | 阴性 | 阳性率 | 阳性 | 阴性 | 阳性率 | 阳性 | 阴性 | 阳性率 | ||
性别 |
|
|
|
|
|
|
|
|
|
|
|
|
|
男 | 36 | 30 | 6 | 83.33% | 10 | 26 | 27.78% | 25 | 11 | 69.44% | 17 | 19 | 47.20% |
女 | 14 | 10 | 4 | 71.43 | 4 | 10 | 28.57% | 10 | 4 | 71.43% | 7 | 7 | 50.00% |
年龄 |
|
|
|
|
|
|
|
|
|
|
|
|
|
≤60 | 23 | 16 | 7 | 69.56% | 9 | 13 | 43.47% | 15 | 8 | 65.22% | 10 | 13 | 43.48% |
>60 | 27 | 22 | 5 | 81.48% | 6 | 21 | 22.22% | 20 | 7 | 74.08% | 12 | 15 | 44.44% |
胃癌部位 |
|
|
|
|
|
|
|
|
|
|
|
|
|
胃体 | 49 | 33 | 16 | 67.34% | 14 | 35 | 28.57% | 34 | 15 | 69.38% | 34 | 15 | 69.39% |
贲门 | 1 | 1 | 0 | 100% | 0 | 1 | 0 | 1 | 0 | 1000% | 1 | 0 | 100% |
组织分化类型 |
|
|
|
|
|
|
|
|
|
|
|
|
|
高 | 6 | 1 | 5 | 16.67%** | 0 | 6 | 0 | 2 | 3 | 33.33%** | 2 | 4 | 33.33%** |
中 | 24 | 13 | 8 | 54.17& | 7 | 17 | 29.17% | 12 | 12 | 50.00% | 17 | 7 | 29.27% |
低 | 20 | 11 | 9 | 55.00% | 6 | 14 | 30% | 13 | 7 | 65.00% | 12 | 8 | 60.00% |
未 | 4 | 3 | 1 | 75.00% | 0 | 4 | 0 | 2 | 1 | 50.00% | 3 | 1 | 75.00% |
分期 |
|
|
|
|
|
|
|
|
|
|
|
|
|
I | 17 | 3 | 15 | 17.64% | 5 | 12 | 29.41% | 3 | 14 | 17.64% | 2 | 15 | 11.76% |
II | 26 | 11 | 15 | 42.30% | 7 | 19 | 26.92% | 13 | 13 | 50.00% | 12 | 14 | 46.15% |
III | 4 | 2 | 2 | 50.00% | 0 | 4 | 0 | 4 | 0 | 100% | 2 | 2 | 50.00% |
IV | 3 | 2 | 1 | 66.67% | 0 | 3 | 0 | 3 | 0 | 100% | 2 | 1 | 66.67% |
浸润深度 |
|
|
|
|
|
|
|
|
|
|
|
|
|
T1 + T2 | 13 | 4 | 9 | 30.76%* | 5 | 8 | 35.71% | 3 | 10 | 23.07%** | 2 | 11 | 15.35%** |
T2 + T3 | 37 | 24 | 13 | 64.86 | 10 | 27 | 27.02% | 27 | 10 | 72.97% | 25 | 12 | 67.57% |
淋巴结转移 |
|
|
|
|
|
|
|
|
|
|
|
|
|
无 | 19 | 5 | 14 | 26.31%** | 5 | 14 | 26.31% | 7 | 12 | 36.84%* | 6 | 13 | 31.57%** |
有 | 31 | 23 | 8 | 74.19% | 9 | 22 | 29.03% | 24 | 7 | 77.41 | 22 | 9 | 70.97 |